O Ondra Health
Semaglutide Tirzepatide ★
How It Works
BMI Calculator Find your body mass index Weight Loss Estimator Project your progress over time Dose Calculator Understand your dosing schedule
FAQ Blog Get Started Patient Portal
Semaglutide Tirzepatide ★
How It Works
BMI Calculator Weight Loss Estimator Dose Calculator
FAQ Blog
Get Started Patient Portal

ONDRA HEALTH

About Us

Ondra Health was built to make accessing treatment feel clear, straightforward, and grounded in real care — not marketing. It's independently owned and operated, combining clinical experience and operational expertise to create a more thoughtful way to navigate GLP-1 treatment.

Why We Built This

This space has become more complicated than it needs to be.

Between inconsistent pricing, unclear information, and platforms that feel more like subscription products than healthcare, it's often difficult to understand what you're actually signing up for.

From a clinical perspective, we've also seen how important it is for treatment to be individualized — not standardized or rushed.

Ondra was built to simplify both sides of that.

What Makes Ondra Different

Our approach is intentionally simple:

  • Transparent, upfront pricing
  • No unnecessary add-ons or bundled services
  • Provider-led care based on your individual health profile
  • Medications fulfilled through state-licensed compounding pharmacies

We focus on removing friction — not adding to it.

How Care Works

Ondra Health is a platform that connects patients with independent, licensed healthcare providers.

All medical evaluations, prescriptions, and treatment decisions are made by those providers. Medications are fulfilled by regulated compounding pharmacies based on your prescription and location.

Our role is to make that process easier to access, easier to understand, and easier to manage.

Care & Communication

Access is only part of the experience — communication matters just as much.

You should be able to ask questions, understand your options, and feel supported throughout your treatment — not left figuring things out on your own.

We've built Ondra to feel more direct, responsive, and transparent than traditional platforms. As we grow, our focus is to maintain that level of clarity and support across every interaction.

Built to Be Clear

Ondra isn't built around trends, branding, or upsells.

It's built to be something you can rely on — clear information, straightforward access, and honest communication from start to finish.

A Note From Us

Thank you for taking the time to learn about Ondra.

If you choose to move forward with us, our goal is to provide a clear, responsive, and high-quality experience — the kind of care and service we would expect ourselves.

<!-- CMS FIELDS Name: 503A vs 503B Pharmacy: What's the Difference for GLP-1s in 2026? Slug: 503a-vs-503b-pharmacy-difference Category: Medication Guides Read Time: 7 min read --> <section class="ondra-article-page"> <div class="ondra-article-hero"> <div class="ondra-article-container"> <div class="ondra-article-meta-row"><span class="ondra-meta-pill">⏱ 7 min read</span><span class="ondra-meta-pill">🏷 Medication Guides</span></div> <h1 class="ondra-article-title">503A vs 503B Pharmacy: What's the Difference for GLP-1s in 2026?</h1> <p class="ondra-article-intro">A 503A pharmacy compounds medication for a specific patient under a prescription. A 503B facility produces larger batches under FDA oversight. In 2026, only 503A is the legal pathway for compounded semaglutide and tirzepatide. Here is what each means and why it matters when choosing a GLP-1 platform.</p> </div> </div> <div class="ondra-article-container ondra-article-body"> <div class="ondra-article-layout" id="ondraArticleLayout"> <div class="ondra-article-main" id="ondraArticleMain"> <a href="/blog" class="ondra-back-link">← Back to all articles</a> <div class="ondra-takeaways-card"> <h2 class="ondra-card-heading">Key takeaways</h2> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>503A pharmacies compound medications for specific patients under valid prescriptions, regulated by state boards. This is the legal 2026 pathway for compounded GLP-1s.</p></div><div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>503B outsourcing facilities produce larger batches under FDA oversight but can no longer legally compound semaglutide (May 2025) or tirzepatide (March 2025).</p></div><div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>A platform that does not name its pharmacy makes it impossible to verify whether your medication comes from a compliant 503A source.</p></div><div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>PCAB accreditation is a voluntary third-party quality signal for 503A pharmacies — Hallandale Pharmacy, one of Ondra's partners, holds PCAB accreditation.</p></div><div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>All of Ondra Health's pharmacy partners are 503A licensed. Their names, license types, and state coverage are listed publicly.</p></div> </div> <div class="ondra-section"><h2>The one-sentence version</h2><p>A <strong>503A pharmacy</strong> compounds medication for a specific patient under a prescription — this is the legal pathway. A <strong>503B facility</strong> produced larger batches for distribution — this pathway is now closed for semaglutide and tirzepatide.</p></div><div class="ondra-section"><h2>503A pharmacies: what they are</h2><p>Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies. A 503A pharmacy operates under a state pharmacy board license, compounds medications only for specific named patients under valid patient-specific prescriptions, follows USP &lt;797&gt; sterile compounding standards for injectables, and may voluntarily seek PCAB accreditation for additional third-party quality verification.</p><p>The key phrase is <em>patient-specific prescription</em>. A 503A pharmacy cannot produce a batch of semaglutide vials for general distribution. Each vial must be prepared in response to a prescription for a named patient — meaning the entire supply chain starts with a licensed provider's clinical evaluation.</p></div><div class="ondra-section"><h2>503B outsourcing facilities: what they are</h2><p>Section 503B was added to the FD&amp;C Act in 2013. A 503B facility is registered with and inspected by the FDA, can produce compounded medications in larger volumes without patient-specific prescriptions, and must follow FDA Current Good Manufacturing Practice (cGMP) standards. 503B facilities became a significant source of compounded GLP-1s during the 2022–2025 shortage period. That pathway is now closed for GLP-1 medications.</p><div class="ondra-info-card"><p class="ondra-info-title">Why 503B is now closed for GLP-1s</p><p>FDA enforcement discretion — which allowed 503B compounding during the shortage — ended for tirzepatide on March 19, 2025 and for semaglutide on May 22, 2025. In April 2025, a district court denied a preliminary injunction against FDA enforcement in <em>Outsourcing Facilities Association v. FDA</em> (N.D. Tex.), upholding the FDA's authority. 503B facilities that continue to compound these medications are operating outside current FDA enforcement policy.</p></div></div><div class="ondra-section"><h2>Side by side: 503A vs 503B in 2026</h2><div class="ondra-info-card"><p class="ondra-info-title">503A pharmacy</p><p><strong>Regulator:</strong> State board of pharmacy<br/><strong>Requires patient-specific Rx:</strong> Yes<br/><strong>Batch production allowed:</strong> No<br/><strong>FDA inspection:</strong> No (state-regulated)<br/><strong>Voluntary accreditation:</strong> PCAB (via ACHC)<br/><strong>GLP-1 compounding status (2026):</strong> Legal with documented clinical justification</p></div><div class="ondra-info-card"><p class="ondra-info-title">503B outsourcing facility</p><p><strong>Regulator:</strong> FDA (cGMP standards)<br/><strong>Requires patient-specific Rx:</strong> No<br/><strong>Batch production allowed:</strong> Yes<br/><strong>FDA inspection:</strong> Yes<br/><strong>GLP-1 compounding status (2026):</strong> No longer legal for semaglutide or tirzepatide</p></div></div><div class="ondra-section"><h2>Why this matters when choosing a platform</h2><p>When you use a GLP-1 telehealth platform, the type of pharmacy that fills your prescription determines whether your medication is legally compliant. You can only verify this if the pharmacy is named.</p><p>Platforms that do not name their pharmacies make this verification impossible. Before starting any compounded GLP-1 program, confirm the pharmacy is identified by name, its license type (503A or 503B) is stated, and you can independently verify its state license and PCAB accreditation.</p><p>Ondra Health names all five of its active pharmacy partners publicly with license type, state restrictions, formulation details, and website links — available at <a href="https://ondra.health/pharmacy-partners">ondra.health/pharmacy-partners</a> before you pay anything.</p></div><div class="ondra-section"><h2>PCAB accreditation: what it adds</h2><p>PCAB (Pharmacy Compounding Accreditation Board), administered by ACHC, is a voluntary third-party accreditation for 503A pharmacies that goes beyond minimum state licensing. PCAB-accredited pharmacies undergo regular independent audits covering sterility procedures, environmental monitoring, quality testing, and operational controls.</p><p>PCAB accreditation does not constitute FDA approval — compounded medications remain not FDA-approved regardless of accreditation status. But it provides an independent quality signal beyond the minimum. Hallandale Pharmacy, one of Ondra's 503A partners, holds PCAB accreditation.</p></div> <div class="ondra-section"> <h2>Frequently asked questions</h2> <div class="ondra-faq-item"><h3>Can a 503B facility still sell compounded GLP-1s to patients?</h3><p>No. FDA enforcement discretion for 503B tirzepatide compounding ended March 19, 2025 and for semaglutide ended May 22, 2025. 503B facilities compounding these medications are operating outside current FDA policy.</p></div><div class="ondra-faq-item"><h3>How do I verify whether my pharmacy is 503A or 503B?</h3><p>The pharmacy should be identified by name. You can then look up its license on the state board of pharmacy website. 503B facilities are also listed on the FDA's registered outsourcing facility database. If your platform does not name the pharmacy, this verification is not possible.</p></div><div class="ondra-faq-item"><h3>Is 503B medication higher quality than 503A?</h3><p>Not necessarily — and that's not the relevant question in 2026. The question is legal status. 503A pharmacies following USP <797> standards and holding PCAB accreditation produce high-quality sterile compounded medications. 503B's stricter FDA oversight was about manufacturing scale, not quality superiority. In 2026, 503A is simply the legal pathway for GLP-1 compounding.</p></div><div class="ondra-faq-item"><h3>Does Ondra Health use 503B pharmacies?</h3><p>Ondra's pharmacy partners are 503A licensed. White Label/Nova Pharmacy holds dual 503A and 503B licensure, but all GLP-1 prescriptions through Ondra are dispensed under 503A patient-specific prescription pathways.</p></div> </div> <p class="ondra-disclaimer">† This article is for informational purposes only and does not constitute legal advice. Regulatory information is current as of June 2026. The GLP-1 compounding regulatory environment continues to evolve — verify current FDA guidance for the most up-to-date status. Compounded medications are not FDA-approved.</p> </div> <aside class="ondra-article-sidebar" id="ondraSidebarCol"> <div class="ondra-sidebar-track" id="ondraSidebarTrack"> <div class="ondra-sidebar-card-wrap" id="ondraSidebarWrap"> <div class="ondra-sidebar-card" id="ondraSidebarCard"> <div class="ondra-sidebar-top"> <p class="ondra-sidebar-eyebrow">ONDRA HEALTH</p> <h3>503A licensed pharmacies, named publicly — from $149/mo</h3> </div> <div class="ondra-sidebar-bottom"> <div class="ondra-sidebar-item"><span><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>All pharmacy partners are 503A licensed</p></div><div class="ondra-sidebar-item"><span><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Named publicly with license type and state availability</p></div><div class="ondra-sidebar-item"><span><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Hallandale Pharmacy is PCAB accredited</p></div><div class="ondra-sidebar-item"><span><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Prescriptions issued by Wasef Health, PC providers</p></div> <a href="https://intake.ondra.health/start-online-visit/glp1" class="ondra-sidebar-button">Start your intake <span aria-hidden="true">→</span></a> <p class="ondra-sidebar-note">Only charged if a provider approves your treatment.</p> </div> </div> </div> </div> </aside> </div> </div> </section>
O
Ondra Health

Personalized GLP-1 treatment plans, guided by licensed providers who care about your journey.

Verify Approval for www.ondra.health

Navigate

Home Patient Portal

Treatments

Semaglutide Tirzepatide Service Areas

Tools

BMI & Weight Loss GLP-1 Eligibility Weight Loss Timeline Calorie Calculator Protein & Water Dose Calculator

Resources

FAQ Blog GLP-1 Reference Pharmacy Partners Contact Us

Legal

Terms of Service Privacy Policy Refund Policy HIPAA Policy Safety Information
Leave Us a Review
Review Us on Trustpilot

© 2026 Ondra Health Inc. All rights reserved.

Ondra Health provides access to telehealth services and compounded medications through licensed providers and pharmacies.